Related Experiment Video
Updated: Aug 9, 2025
05:57
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
824
Antihypertensives in Pregnancy.
Anna E Denoble1, Sarah A Goldstein2, Christian M Pettker1
1Section of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
Obstetrics and Gynecology Clinics of North America
|February 23, 2023
Summary
Hypertensive disorders in pregnancy require careful management. Many blood pressure medications are safe for pregnant patients with close monitoring of fetal development and amniotic fluid.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Pharmacology
Background:
- Hypertensive disorders of pregnancy (HDP) pose significant risks, including maternal morbidity and mortality.
- Effective management is crucial for improving maternal and fetal outcomes.
Purpose of the Study:
- To summarize current guidelines for diagnosing and treating hypertension during pregnancy.
- To provide a comprehensive review of antihypertensive medication safety and efficacy in pregnancy and postpartum.
Main Methods:
- Literature review of current clinical guidelines.
- Analysis of safety and efficacy data for antihypertensives in pregnant populations.
- Synthesis of evidence for clinical practice recommendations.
Main Results:
- Several antihypertensive medications are considered safe for use in pregnant patients.
- Close monitoring of fetal growth and amniotic fluid volume is essential.
- Guidelines provide a framework for diagnosis and treatment.
Conclusions:
- Antihypertensive therapy can be safely administered in pregnancy under close medical supervision.
- This review offers guidance for healthcare providers managing hypertension in pregnant and postpartum patients.
- Adherence to guidelines and vigilant monitoring are key to optimizing outcomes.
Related Concept Videos
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
543
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
543
01:16Antihypertensive Drugs: Action of Diuretics
826
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
826
01:23Antihypertensive Drugs: Vasodilators
593
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
593
01:33Hormonal Regulation
33.5K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.5K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
737
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
737
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
26
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
26